Search Results 311-320 of 780 for ⚕베스트토토검증완료【평생베스트.com】베스트토토검증완료⚕

  1. Selinexor in Advanced Liposarcoma - Clinical Trials

    This is a randomized, multicenter, double-blind, placebo-controlled, Phase 2-3 study of patients diagnosed with advanced unresectable dedifferentiated ...

  2. Study to Validate Auto Registry and Integration of Ultrasound into Procedure - Mayo Clinic

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 18-005963. Sponsor Protocol Number: 18-005963. About this study. The purpose of this study is to compare the ...

  3. A Study to Evaluate Endoflip Normal Ranges Data in Healthy Volunteers - Mayo Clinic

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 20-012285. NCT ID: NCT04809883. About this study. The purpose of this research is to establish the normal range ...

  4. A Study of Disease Prediction for NOTCH3 - Mayo Clinic

    ... best. Study IDs. Site IRB. Jacksonville, Florida: 24-013764. About this study. The purpose of this study is to assess NOTCH3-SVD disease progression and develop ...

  5. Gastroenterology and Hepatology - Clinical trials

    In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in the ...

  6. A Phase 1B Dose-escalation Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma - Mayo Clinic

    ... best. Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  7. Clinical trials - Gastroenterology and Hepatology

    Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...

  8. A Study to Evaluate the Effectiveness and Safety of Glepaglutide in the Treatment of Short Bowel Syndrome - Mayo Clinic

    The primary purpose of this trial is to confirm the effectiveness of glepaglutide in reducing parenteral support volume in patients with short bowel syndrome.

  9. A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) - Mayo Clinic

    ... best. Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  10. A Study of Clinical Score Usefulness and Electronic Health Record Integration

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 15-009228. NCT ID: NCT02755025. Sponsor Protocol Number: 15-009228. About this study. The SOFA score is a ...